Buscar en
Endocrinología y Nutrición
Toda la web
Inicio Endocrinología y Nutrición Tratamientos coadyuvantes del hirsutismo
Información de la revista
Vol. 52. Núm. 7.
Páginas 365-373 (Septiembre 2005)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 52. Núm. 7.
Páginas 365-373 (Septiembre 2005)
Revisiones
Acceso a texto completo
Tratamientos coadyuvantes del hirsutismo
Complementary treatments for hirsutism
Visitas
...
A. Becerra
Autor para correspondencia
abecerra@telefonica.net

Correspondencia: Dr. A. Becerra Fernández. Servicio de Endocrinología. Hospital Ramón y Cajal. niversidad de Alcalá. Ctra. Colmenar, km 9,100. 28034 Madrid. España.
Servicio de Endocrinología. Hospital Ramón y Cajal. Universidad de Alcalá. Madrid. España
Información del artículo

El hirsutismo es el crecimiento excesivo de pelo terminal en la mujer, que se localiza principalmente en áreas de la piel sensibles a los andrógenos, de patrón masculino. Es una entidad muy frecuente que suele formar parte de un cuadro clínico más florido. Sin embargo, no siempre corresponde a una patología per se, y representa una situación de gran malestar estético, de consecuencias psicosociales que comprometen la calidad de vida de las mujeres afectadas. En la práctica clínica, el hirsutismo tiene que evaluarse mediante una escala. El tratamiento farmacológico sirve para detener el crecimiento del nuevo vello, pero no del ya formado, y su máximo efecto no se hace patente hasta pasados muchos meses. Por eso debe acompañarse de otros tratamientos que de manera más rápida y efectiva eliminen el vello no deseado. La fotodepilación con rayos láser ha demostrado ser un método seguro, eficaz y duradero.

Palabras clave:
Hirsutismo
Depilación
Láser

Hirsutism is the excessive growth of terminal hair in women, localized mainly on androgen-sensitive skin areas, with a male pattern of distribution. It is a highly frequent entity that usually forms part of a more complex clinical picture. However, it does not always correspond to a disease per se and causes social and psychological distress that compromises the quality of life of affected women. In clinical practice, hirsutism must be evaluated on a scale. Pharmacological treatment delays the growth of new hair, but does not affect existing hair and its maximal effect does not become evident for many months. Therefore, pharmacological treatment should be completed by other treatments that remove the unwanted hair. Laser hair removal has been demonstrated to be a safe, effective and lasting method.

Key words:
Hirsutism
Depilation
Laser
El Texto completo está disponible en PDF
Bibliografía
[1.]
E. McKnight.
The prevalence of “hirsutism” in young women.
Lancet, 1 (1964), pp. 410-413
[2.]
D. Ferriman, J.D. Gallwey.
Clinical assessment of body hair growth in women.
J Clin Endocrinol Metab, 21 (1961), pp. 1440-1447
[3.]
E. Diamanti-Kandarakis, C.R. Kouli, A.T. Bergiele, F.A. Filandra, T.C. Tsianateli, G.G. Spina, et al.
A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.
J Clin Endocrinol Metab, 84 (1999), pp. 4006-4011
[4.]
R. Azziz, E. Carmina, M.E. Azuaya.
Idiopathic hirsutism.
Endocr Rev, 21 (2000), pp. 347-362
[5.]
M. Asunción, R.M. Calvo, J.L. San Millán, J. Sancho, S. Ávila, H.F. Escobar-Morreale.
A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.
J Clin Endocrinol Metab, 85 (2000), pp. 2434-2438
[6.]
R. Azziz.
The Evaluation and management of hirsutism.
Obstet Gynecol, 101 (2003), pp. 995-1007
[7.]
N. Sonino, G.A. Fava, E. Mani, P. Belluardo, M. Boscaro.
Quality of life of hirsute women.
Postgrad Med, 69 (1993), pp. 186-189
[8.]
J.H. Barth, J. Catalan, C.A. Cherry, A. Day.
Psychological morbidity in women referred for treatment of hirsutism.
J Psychosom Res, 37 (1993), pp. 615-619
[9.]
V.A. Randall.
Androgens and human hair growth.
Clin Endocrinol, 40 (1994), pp. 439-457
[10.]
R.K. Freinkel, N. Freinkel.
Hair growth and alopecia in hypothyroidism.
Arch Dermatol, 106 (1972), pp. 349-352
[11.]
A.G. Messenger.
Thyroid hormone and hair growth.
Br J Dermatol, 142 (2000), pp. 633-634
[12.]
E.J. Giltay, L.J. Gooren.
Effects of sex steroid deprivation/administration on hair growth and skin sebum production in transsexual males and females.
J Clin Endocrinol Metab, 85 (2000), pp. 2913-2921
[13.]
D. Deplewski, R.L. Rosenfield.
Role of hormones in pilosebaceous unit development.
Endocr Rev, 21 (2000), pp. 363-392
[14.]
R. Hatch, R.L. Rosenfield, M.H. Kim, D. Tredway.
Hirsutism: Implications, etiology, and management.
Am J Obstet Gynecol, 140 (1981), pp. 815-830
[15.]
J.D.R. Peereboom-Wynia, E. Stolz, T. Van Joost, H. Kleiman.
A comparative study of the effects of electrical epilation of beard hairs in women with hirsutism by diathermy and by the blend method.
Arch Dermatol Res, 278 (1985), pp. 84-86
[16.]
R.N. Richards, G.E. Meharg.
Electrolysis: observations from 13 years and 140,000 hours of experience.
J Am Acad Dermatol, 33 (1995), pp. 662-666
[17.]
A.P. Soler, G. Gilliard, L.C. Megosh, T.G. O’Brien.
Modulation of murine hair follicle function by alterations in ornithine decarboxylase activity.
J Invest Dermatol, 106 (1996), pp. 1108-1113
[18.]
J.A. Balfour, McClellank.
Topical Efloanithine.
An Clin Dermatol, 2 (2001), pp. 197-201
[19.]
C.C. Dierickx, M.C. Grossman, W.A. Farinelli, R.R. Anderson.
Permanent hair removal by normal mode ruby laser.
Arch Dermatol, 134 (1998), pp. 837-842
[20.]
T.Y.D. Lin, W. Manuskiatti, C.C. Dierickx, W.A. Farinelli, M.E. Fisher, T. Flotte, et al.
Hair growth cycle affects hair follicle destruction by ruby laser pulses.
J Invest Dermatol, 111 (1998), pp. 107-113
[21.]
N. Bouzari, H. Tabatabai, Z. Abbasi, A. Firooz, Y. Dowlati.
Hair removal using an 800-nm Diode Laser: Comparison at different treatment intervals of 45, 60, and 90 days.
Int J Dermatol, 44 (2005), pp. 50-53
[22.]
S. Eremia, C. Li, N. Newman.
Laser hair removal with alexandrite versus diode laser using four treatment sessions: 1-year results.
Dermatol Surg, 27 (2001), pp. 925-929
[23.]
S.H. Liew.
Laser hair removal: guidelines for management.
Am J Clin Dermatol, 3 (2002), pp. 107-115
[24.]
K.B. Marayiannis, S.P. Vlachos, M.P. Savva, P.P. Kontoes.
Efficacy of long- and short pulse alexandrite lasers compared with an intense pulsed light source for epilation: a study on 532 sites in 389 patients.
J Cosmet Laser Ther, 5 (2003), pp. 140-145
[25.]
G. Lask, S. Eckhouse, M. Slatkine, A. Waldman, M. Kreindel, V. Gottfried.
The role of laser and intense light sources in photo-depilation: a comparative evaluation.
J Cutan Laser Ther, 1 (1999), pp. 3-13
[26.]
V.G. Kolinko, C.M. Littler, A. Cole.
Influence of the anagen:telogen ratio on Q-switched Nd:YAG laser hair removal efficacy.
Lasers Surg Med, 26 (2000), pp. 33-40
[27.]
C.C. Dierickx.
Hair removal by lasers and intense pulsed light sources.
Semin Cutan Med Surg, 19 (2000), pp. 267-275
[28.]
C.A. Schroeter, J.S. Groenewegen, T. Reineke, H.A. Neumann.
Hair reduction using intense pulsed light source.
Dermatol Surg, 30 (2004), pp. 168-173
[29.]
N.S. Sadick, J. Shaoul.
Hair removal using a combination of conducted radiofrequency and optical energies-an 18-month follow-up.
J Cosmet Laser Ther, 6 (2004), pp. 21-26
[30.]
V.G. Lacombe.
Laser hair removal.
Facial Plast Surg, 20 (2004), pp. 85-89
[31.]
C.A. Schroeter, J.S. Groenewegen, T. Reineke, H.A. Neumann.
Ninety percent permanent hair reduction in transsexual patients.
Ann Plast Surg, 51 (2003), pp. 243-248
[32.]
G.A. Moreno-Arias, C. Castelo-Branco, J. Ferrando.
Side-effects after IPL photodepilation.
Dermatol Surg, 28 (2002), pp. 1131-1134
Copyright © 2005. Sociedad Española de Endocrinología y Nutrición
Opciones de artículo
Herramientas
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos